Phase I pilot study with 5 patients with hemophilia for assessment by myofascial therapy protocol designed for this purpose.
Phase II. Randomized, prospective longitudinal clinical study in patients with hemophilia, to assess the efficacy of an intervention with myofascial therapy.
Age
18–65
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with a diagnosis of hemophilia A and B.
Patients older than 18 years.
Patients with a diagnosis of hemophilic arthropathy of the knee and ankle.
Patients on prophylactic regimen with FVIII / FIX.
You may not be if
Patients without walking ability.
Patients with a diagnosis of other congenital coagulopathy (eg von Willebrand disease).
Patients who have developed antibodies to FVIII / FIX (inhibitors).
Patients with neurological or cognitive impairments that impede understanding of questionnaires and physical test.
Patients who have not signed the informed consent document.
Clareo Health | Myofascial Therapy in Patients With Hemophilic Arthropathy
